Pregnancies during and following trastuzumab (T) and/or lapatinib (L) in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials Meeting Abstract
| Authors: | Lambertini, M.; Martel, S.; Campbell, C.; Guillaume, S.; Hilbers, F.; Schuehly, U.; Korde, L.; Azim, H. A.; Di Cosimo, S.; Tenglin, R. C.; Huober, J. B.; Baselga, J.; Moreno-Aspitia, A.; Piccart-Gebhart, M. J.; Gelber, R. D.; De Azambuja, E.; Ignatiadis, M. |
| Abstract Title: | Pregnancies during and following trastuzumab (T) and/or lapatinib (L) in patients (pts) with HER2-positive (HER2+) early breast cancer (EBC): Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 532s |
| Language: | English |
| ACCESSION: | WOS:000442916003430 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.10065 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10065 -- Source: Wos |
